After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Calidi Biotherapeutics Inc is listed on the AMEX in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Calidi Biotherapeutics Inc is $8.08M. A total of 0.3 million shares were traded on the day, compared to an average of 1.54M shares.
In the most recent transaction, Schoeneck James A bought 75,000 shares of CLDI for 2.00 per share on Aug 21 ’25. After the transaction, the Director now owns 76,134 company shares. In a previous transaction on Aug 21 ’25, Poma Eric E bought 25,000 shares at 2.00 per share. CLDI shares that Chief Executive Officer owns now total 25,000.
Among the insiders who bought shares, Leftwich Scott acquired of 125,000 shares on Aug 21 ’25 at a per-share price of $2.00. This resulted in the Director holding 130,650 shares of CLDI after the transaction. In another insider transaction, Jackson Andrew C. bought 2,500 shares at $2.00 per share on Aug 21 ’25. Company shares held by the Chief Financial Officer now total 2,500.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CLDI has a high of $46.68 and a low of $1.54.
As of this writing, CLDI has an earnings estimate of -$1.2 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$1.2 per share and a lower estimate of -$1.2. The company reported an EPS of -$7.8 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CLDI’s latest balance sheet shows that the firm has $2.14M in Cash & Short Term Investments as of fiscal 2021. There were $5.18M in debt and $25.96M in liabilities at the time. Its Book Value Per Share was $0.61, while its Total Shareholder’s Equity was -$31.61M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLDI is Buy with a score of 4.00.
